Core lipid, surface lipid and apolipoprotein composition analysis of lipoprotein particles as a function of particle size in one workflow integrating asymmetric flow field-flow fractionation and liquid chromatography-tandem mass spectrometry
Open Access
- 10 April 2018
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 13 (4) , e0194797
Abstract
Lipoproteins are complex molecular assemblies that are key participants in the intricate cascade of extracellular lipid metabolism with important consequences in the formation of atherosclerotic lesions and the development of cardiovascular disease. Multiplexed mass spectrometry (MS) techniques have substantially improved the ability to characterize the composition of lipoproteins. However, these advanced MS techniques are limited by traditional pre-analytical fractionation techniques that compromise the structural integrity of lipoprotein particles during separation from serum or plasma. In this work, we applied a highly effective and gentle hydrodynamic size based fractionation technique, asymmetric flow field-flow fractionation (AF4), and integrated it into a comprehensive tandem mass spectrometry based workflow that was used for the measurement of apolipoproteins (apos A-I, A-II, A-IV, B, C-I, C-II, C-III and E), free cholesterol (FC), cholesterol esters (CE), triglycerides (TG), and phospholipids (PL) (phosphatidylcholine (PC), sphingomyelin (SM), phosphatidylethanolamine (PE), phosphatidylinositol (PI) and lysophosphatidylcholine (LPC)). Hydrodynamic size in each of 40 size fractions separated by AF4 was measured by dynamic light scattering. Measuring all major lipids and apolipoproteins in each size fraction and in the whole serum, using total of 0.1 ml, allowed the volumetric calculation of lipoprotein particle numbers and expression of composition in molar analyte per particle number ratios. Measurements in 110 serum samples showed substantive differences between size fractions of HDL and LDL. Lipoprotein composition within size fractions was expressed in molar ratios of analytes (A-I/A-II, C-II/C-I, C-II/C-III. E/C-III, FC/PL, SM/PL, PE/PL, and PI/PL), showing differences in sample categories with combinations of normal and high levels of Total-C and/or Total-TG. The agreement with previous studies indirectly validates the AF4-LC-MS/MS approach and demonstrates the potential of this workflow for characterization of lipoprotein composition in clinical studies using small volumes of archived frozen samples.Keywords
Funding Information
- Centers for Disease Control and Prevention (None)
- Centers for Disease Control and Prevention
This publication has 60 references indexed in Scilit:
- Volumetric determination of apolipoprotein stoichiometry of circulating HDL subspeciesJournal of Lipid Research, 2013
- Apolipoprotein E in VLDL and LDL With Apolipoprotein C‐III is Associated With a Lower Risk of Coronary Heart DiseaseJournal of the American Heart Association, 2013
- Low-Density Lipoproteins Containing Apolipoprotein C-III and the Risk of Coronary Heart DiseaseCirculation, 2011
- Lipidomics reveals a remarkable diversity of lipids in human plasmaJournal of Lipid Research, 2010
- Lipoproteomics: using mass spectrometry-based proteomics to explore the assembly, structure, and function of lipoproteinsJournal of Lipid Research, 2009
- Fractionation of human serum lipoproteins and simultaneous enzymatic determination of cholesterol and triglyceridesAnalytica Chimica Acta, 2009
- Mass spectrometric determination of apolipoprotein molecular stoichiometry in reconstituted high density lipoprotein particlesJournal of Lipid Research, 2009
- Size and Shape of Protein Molecules at the Nanometer Level Determined by Sedimentation, Gel Filtration, and Electron MicroscopyBiological Procedures Online, 2009
- Separation of Lipoproteins From Human Plasma by Flow Field-Flow FractionationJournal of Liquid Chromatography & Related Technologies, 1997
- Monoclonal antibodies against human low density lipoproteinFEBS Letters, 1982